US CRO Celerion gained Brazilian National Health Surveillance Agency (Agência Nacional de Vigilancia Sanitaria ANVISA) approval for its bioanalysis labs in Lincoln, Nebraska and in Belfast, Northern Ireland.
in-PharmaTechnologist.com presents its latest round up of movements in the pharma sector, including appointments at PhRMA, Dyax, Alnylam, Avi BioPharma, Pacira, Asmacure and Xceleon.
PolyPid claims its new polymer-lipid combination delivery tech will let pharmas set precise release characteristics for a variety of small molecule, protein and nucleic acid-base drugs.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Aphena, Acino and blue inspection body.
UK-based drugmaker Shire has unveiled plans to buy Advanced BioHealing (ABH) citing the lack of generic competition in the regenerative medicines sector as a factor.
US-based vaccine specialist, Caliber Biotherapeutics, has opened the world’s largest modular, plant-made pharmaceutical manufacturing facility at its headquarters in Bryan, Texas.
SciComPro, life sciences consultancy firm based in Ohio, US, has partnered with clinical trials specialist, Community Research, to conduct clinical trials for a number of new medical device products.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Hemispherx Biopharma, Novartis and InVivo.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at INC Research, DPT, PharmaNet and CTI.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at PhRMA, BIO, Shire, Eli Lilly and DPT Laboratories.
US-based Numira Biosciences has expanded its imaging and pre-clinical services portfolio after acquiring the efficacy pharmacology operating unit of Ricerca Biosciences.
The EU and US are using substandard medicines as an excuse to tighten IP rules, boosting pharma profits while making it harder for the poor to access drugs, according to Oxfam.
PsiOxus Therapeutics has predicted growing demand for oncolytic vaccines, citing recent industry acquisitions as evidence of the need for novel treatments for cancer.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Catalent, Norwich Pharmaceuticals and Prism Ideas.
Creation of a “one-stop shop” for health research approval would free the UK from overly burdensome regulations that are stifling innovation, according to a report.
Pacific Biomarkers has established a scientific advisory board (SAB) to help it evaluate new technologies and opportunities in the clinical research sector.
PR-based strategies emphasising the cost of the disease and local partners are needed to enter the lucrative German vaccine market, according to researchers.
Bayer HealthCare is investing €35m ($47m) in a new centre for the biotechnological production of ‘innovative’ pharmaceuticals to be used in clinical trials.
US based healthcare distributer, Cardinal Health, has announced the $470m acquisition of privately held healthcare distribution business Zuellig Pharma China, known locally as Yong Yu.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Euthymics, CytomX, NPS Pharmaceuticals and InQ Biosciences.
Novartis aims to focus on the development of specialty medicines in a new long-term strategy to boost profitability in a rapidly changing healthcare environment.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at INC, Perceptive, Althea, Novella and BioClinica.
Clinical Research Advantage (CRA) is introducing its services to the Las Vegas market by opening eight new offices in the region to help trial sponsors bring drugs to market quicker and more effectively.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Aqua Pharmaceuticals, Algeta ASA and Amarin.
Volunteer organisation, the Blue Bird Circle will provide grants of $1m to Texas Children’s Hospital in the US for the establishment of a new clinical research centre.
Quintiles and Dako, a Danish-based cancer diagnostics firm, are teaming up to help speed development of personalised medicine by collaborating on the co-development of targeted oncology therapies and diagnostics.
PPD is collaborating with the Himalayan Institute and Hospital Trust (HIHT University) to form a large investigator site and expand its network of investigators in Northern India.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Trident, Agilux and Clinical Trials of America.
Prosonix expects high demand for innovative particle processing technologies in the $24bn (€17bn) a-year respiratory pharmaceuticals market over the next few years.
The FDA is to collaborate with the WHO to build a global surveillance and monitoring system for combating falsified medicines and breaches of the supply chain.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at INC Research, Velesco, Acurian, Asterand and Cmed.
